% CI #.#-#.# [007]

Related by string. % CI #.#-#.# [002] * : % ON HEAVY . % downside protection . -#.# % [002] . % RETURN SEEN / Cid . ci . CIS . CID : % CI #.#-#.# [006] . % CI #.#-#.# [003] . CI = . confidence interval CI / #.# [010] . #.# [027] . #.# [043] . #.# [031] : #.# ov #-# . Yard Freestyle =-#.# mg dL . #.# Promote sexually / #.# [009] . #.# [022] . #.# [039] : Rs #.# [005] . #.# Advocate promote . #.# ERA * *

Related by context. Frequent words. (Click for all words.) 82 % CI #.#-#.# [006] 81 % CI #.#-#.# [003] 77 confidence interval CI 77 CI #.#-#.# [002] 76 P = .# 76 confidence interval #.#-#.# 75 p = .# [002] 73 % CI #.#-#.# [002] 72 CI -#.# 71 CI = 69 sd = 69 univariate analysis 68 median PFS 67 leukopenia 67 pg ml 66 nonobese 66 biochemical recurrence 66 postop 65 lymphopenia 65 sensory neuropathy 65 p = 65 chlorambucil 65 65 DAS# [002] 64 p = #.# [002] 64 prevalences 64 pg mL 64 TAXUS p value 64 distant metastasis 63 mg kg dose 63 MetS 63 mmol l 63 n = 63 pheochromocytoma 63 febrile neutropenia 63 p = #.# [004] 63 nmol L 62 rheumatoid factor 62 multivariate analyzes 62 virologic failure 62 RECIST criteria 62 placebo p = 62 pulmonary embolus 62 thromboembolism 62 HCV genotype 62 #mg/day [001] 62 renal insufficiency 62 Expanded Disability Status 62 J. Clin 62 plus methotrexate 62 patients evaluable 62 nonsignificant 61 annualized relapse 61 nondiabetic 61 hypokalemia 61 cholangiocarcinoma 61 laboratory abnormalities 61 Secondary endpoints included 61 virologic response 61 μg kg 61 coinfected 61 highest quintile 61 distant metastases 61 Response Evaluation Criteria 61 Median survival 61 chronic rhinosinusitis 61 PCa 61 EBRT 61 hypoxemia 61 neoplasm 61 preoperatively 61 LVEF 61 left ventricular systolic 61 plus dexamethasone 61 thromboembolic events 61 lymph node involvement 61 acneform rash 61 pleural effusion 61 mL kg 60 peginterferon alfa 2a 60 achieved statistical significance 60 thromboembolic 60 mRCC 60 FOLFOX 60 breast carcinoma 60 evaluable 60 IPSS 60 CMV infection 60 serum concentrations 60 seroprotection 60 statistically significant p = 60 Arch Intern Med 60 HbA1c levels 60 FOLFIRI 60 VUR 60 T2DM 60 venous thrombosis 60 lowest quintile 60 mg QD 60 daunorubicin 60 cerebrovascular events

Back to home page